Insurance coverage for GLP-1 medications
The honest version: coverage depends on which medication, which indication, and which plan. Here is what you can expect to encounter.
The split: diabetes vs weight management
Ozempic, Mounjaro, and Trulicity are FDA-approved for type 2 diabetes. Insurance coverage for diabetes is widespread, often with reasonable copays. Wegovy and Zepbound are FDA-approved for chronic weight management. Coverage for weight management is much more variable.
Commercial insurance (employer plans)
Many commercial plans cover Wegovy and Zepbound, sometimes with prior authorization and BMI documentation requirements. Your plan formulary will say whether the drug is covered, what tier it sits on, and what step therapy (try-this-first) is required.
Medicare
Medicare currently has limited coverage for GLP-1 medications used for weight management. Diabetes indications are generally covered. The Inflation Reduction Act has changed some pricing dynamics for diabetes; weight-management coverage remains a moving target.
Medicaid
Coverage varies dramatically by state. Some states cover weight-management GLP-1s with strict criteria, others don't cover them at all. Diabetes indications are more reliably covered.
Manufacturer savings programs
- Novo Nordisk offers a Wegovy and Ozempic savings card for commercially insured patients. The amount saved varies by plan and indication. Check the manufacturer site for current terms.
- Eli Lilly offers Mounjaro and Zepbound savings cards on similar terms. Lilly also operates LillyDirect, a self-pay option for Zepbound single-dose vials at a list price reduction.
Cash pay reality
Without insurance, list prices in the US are roughly $900-$1,350 per month depending on the medication. Self-pay options via manufacturer programs reduce this but rarely to insurance-equivalent levels.
Compounded GLP-1 medications
Compounded semaglutide and tirzepatide are available from some pharmacies during official shortages. These products are not FDA-approved, are not interchangeable with branded products, and quality and consistency vary widely between compounding pharmacies. The FDA has issued advisories about compounded GLP-1s; talk to your prescriber about whether a compounded product is appropriate for your situation.
Prior authorization tips
- Document your BMI accurately on a recent visit note.
- If you have a weight-related condition (hypertension, dyslipidemia, sleep apnea, prediabetes), make sure it is on the chart.
- If your plan requires step therapy, ask your prescriber to document what you have tried.
- Appeals are common and frequently successful.